A new clinical case confirms the efficacy of MLS® for treating Covid-19 pneumonia

12 October 2021 - Research -
Share

New studies and clinical reports confirm that MLS® Laser Therapy is useful for contributing to the treatment of patients with COVID-19 pneumonia.

Used as a complementary treatment to standard drug therapy, MLS® alleviates acute inflammatory events caused by an excessive production of pro-inflammatory cytokines and favours pulmonary functional recovery.

This is confirmed by a recent clinical case concerning a 70-year old patient admitted to hospital with symptoms of respiratory failure, cough, vomiting and chest pain, with X-ray evidence of atypical pneumonia from COVID-19. The patient underwent drug therapy combined with a daily session of MLS® Laser Therapy for 5 days and showed:

  • a significant increase in the level of oxygen saturation, which went from the initial 90% to 98%;
  • a general improvement of his health with a regression of symptoms;
  •  significant decrease of the level of ferritin, recognised as a marker of acute and chronic inflammation.
Chest X-rays before MLS
Chest X-rays after MLS

The chest X-ray carried out both before and after the laser therapy with the M6 device furthermore showed a significant reduction in inflammation (clear and extended lungs, with a decrease in consolidations and opacities).  Although concerning one patient only, the results of the study support the use of MLS® Laser Therapy as an aid to manage patients with interstitial pneumonia.

Testo a Destra
Immagine 30%/Testo 60%

“Use of the MLS® Laser Therapy in the management of SARS-CoV-2 infection: a case report”
L. Cibulka, V. Petrtýlová
Energy For Health [21], 2021

READ MORE

You might also be interested in ...

See all articles

Energy for Health - Scientific review by ASAcampus
news - 01/10/2021
Energy for Health #21: MLS® at the forefront
Four case reports dedicated to applying the MLS® therapy, two in the human field and two in the veterinary field are the focus of the new edition of Energy for Health.
M8 laser treatment for pain due to COVID-19
blog - 09/04/2021
Journal Of Inflammation Research: MLS® Laser Therapy and the consequences of interstitial pneumonia caused by COVID-19
The results actually showed that patients undergoing MLS® Laser Therapy had a rapid recovery
press - 01/09/2020
NBC Boston News: MLS® treats a Covid-19 patient effectively
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
Gruppo El.En and POLIMI @ASA
News - 26/11/2024
Intercompany training: how to manage relationships and company values
“Leadership: managing relationships and company values” is the training course born from the will of El.En., Deka, Quanta Systems, Cutlite Penta and ASA. 
ASAlaser @ Pecs - Hungary
News - 13/11/2024
MLS® Laser Therapy at the centre of a seminar at the Magyar Fisio Kongresszus
Thanks to the collaboration with the local distributor Procardia & Meddevice, present with its own stand, the company staff were able to meet long-standing customers and, at the same time, to...
Hilterapia and nerve function
Blog - 04/11/2024
Exploring the Effects of Hilterapia® on Skin Temperature and Nerve Function
A recent study conducted by Alayat et al. (2024) is the first to examine the effects of Hilterapia® - pulsed Nd:YAG laser source (1064nm) - on skin temperature and nerve function in healthy...